News

April 17, 2023

MatTek and NEXT Oncology Announce Licensing Agreement

MatTek and NEXT Oncology Announce Licensing Agreement
The Boston-based biotech company will use an inventory of patient-derived cancer cells to develop new lab-grown tumor models to accelerate and refine oncology research, and provide more targeted treatments for cancer patients. [For immediate release: Ashland, MA and San Antonio,... Read More